News

Right now, Hartung says scientists can use AI to pull and analyze millions of scientific papers as a way of screening chemical substances for potential problems instead of subjecting zebrafish and ...
Liu’s main research at UW-Madison is in technology systems, pushing them to their limits and breaking them with a purpose. In ...
An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...
Their preclinical studies found that blocking activity of EPO converts formerly “cold” – or immune-resistant – liver tumors in mice into “hot” tumors teeming with cancer-fighting ...
An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins ...
A vaccine under development has demonstrated complete protection in mice against a deadly variant of the virus that causes bird flu. The work focuses on the H5N1 variant known as 2.3.4.4b, which has ...
An experimental drug now in clinical trials ... In addition, they gave some of the mice navitoclax, a Bcl-2 inhibitor currently in clinical trials to treat cancer by accelerating programmed cell death ...
Credit: Provided. The threat of rising cancer cases in the future statewide has prompted the Medical University of South Carolina (MUSC) to plan for a new cancer hospital in downtown Charleston.
“One group consistently neglected by those developing health plans and policies is teenagers and young adults with cancer. “The impact can be devastating.” The duchess has previously ...
First preclinical data of novel targeted Radio-DARPin against mesothelin (MSLN), in co-development with Orano Med "Our presentations at AACR highlight the breadth of Molecular Partners' DARPin ...